(Q46158181)

20 December 2017

title

Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate (English)

1 reference

20 December 2017

1 reference

1 reference

A Poggi

1

1 reference

20 December 2017

S Catellani

2

1 reference

20 December 2017

A Garuti

3

1 reference

20 December 2017

I Pierri

4

1 reference

20 December 2017

M Gobbi

5

1 reference

20 December 2017

M R Zocchi

6

1 reference

20 December 2017

publication date

8 January 2009

1 reference

20 December 2017

published in

Leukemia

1 reference

20 December 2017

volume

23

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

641-648

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1038/leu.2008.354

exact match

0 references

cites work

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Regulation of cutaneous malignancy by gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Human gammadelta T cells: a nonredundant system in the immune-surveillance against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Proteolytic release of soluble UL16-binding protein 2 from tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

CD107a as a functional marker for the identification of natural killer cell activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

Expansion of Vdelta1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.354

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2008.354

1 reference

20 December 2017

Dimensions Publication ID

0 references

1 reference

20 December 2017